InspireMD (Nasdaq:NSPR) announced today that it completed a full exercise of Series H warrants for proceeds of about $17.9 million. Tel Aviv, Israel-based InspireMD exercised 12.9 million warrants, converting primarily into pre-funded warrants. The gross proceeds for the company, which has a U.S. base in Westin, Florida, total $16.9 million … [Read more...] about InspireMD brings in $17.9M to support stent trial
Business
Medtronic launches Steerant aortic guidewire
Medtronic (NYSE:MDT) today announced the launch of its Steerant aortic guidewire in the U.S. and Canada following the first patient cases. The medtech giant tailored Steerant to facilitate catheter placement and exchange during diagnostic or interventional aortic procedures. It designed the guidewire to support endovascular aneurysm repair … [Read more...] about Medtronic launches Steerant aortic guidewire
Zeus has a new catheters GM
NEWS RELEASE: Zeus welcomes new general manager, reinforcing commitment to catheter innovation Orangeburg, South Carolina – Zeus, a world leader in polymer extrusion and catheter manufacturing, is pleased to announce a pivotal addition to its leadership team, reflecting an unwavering commitment to innovation and excellence in providing solutions … [Read more...] about Zeus has a new catheters GM
FastWave reports positive 30-day results in first-in-human IVL study
FastWave Medical today announced successful 30-day results from the first-in-human study of its intravascular lithotripsy (IVL) technology. Minneapolis-based FastWave develops laser-based IVL technology for treating calcific artery disease. Its platform offers durable and fast energy delivery with enhanced sonic output. The system helps to … [Read more...] about FastWave reports positive 30-day results in first-in-human IVL study
Surmodics to be acquired by private equity firm for $627M
Surmodics (Nasdaq:SRDX) announced today that it agreed to be acquired by GTCR, a private equity firm with healthcare interests. Eden Prairie, Minnesota-based Surmodics develops a range of technologies, including drug-coated balloons and thrombectomy systems. Its SurVeil DCB received a long-awaited FDA approval in June 2023. The company also … [Read more...] about Surmodics to be acquired by private equity firm for $627M
Vantis Vascular raises $5M for microcatheter, IVL system
Vantis Vascular announced today that it closed a $5 million SAFE (Simple Agreement for Future Equity) financing round. The company can convert the financing upon its future Series C preferred financing round. It brings the total funding for the company to $24 million to date. San Jose, California-based Vantis plans to use the funds to advance … [Read more...] about Vantis Vascular raises $5M for microcatheter, IVL system
Atraverse wins FDA nod for left-heart access device, raises $12.5M
Atraverse Medical announced today that the FDA cleared its Hotwire radiofrequency guidewire left-heart access device. The novel device enables zero exchange left-heart access while acting as a rail for catheter-based therapy systems. Steven Mickelsen, the founder of Farapulse, invented the Hotwire system with co-founder Eric Sauter. It's the … [Read more...] about Atraverse wins FDA nod for left-heart access device, raises $12.5M
Stereotaxis to acquire Access Point Technologies and its EP catheters
Stereotaxis (NYSE: STXS) is purchasing a Minneapolis-based electrophysiology (EP) catheter maker to further enhance its minimally invasive endovascular surgical robotics technology. St. Louis–based Stereotaxis did not disclose how much it is paying for Access Point Technologies in its after-hours news release. The transaction, paid with … [Read more...] about Stereotaxis to acquire Access Point Technologies and its EP catheters
Cerevasc raises $70M Series B to support eShunt
CereVasc announced today that it completed the initial closing of its Series B funding round worth $70 million. Bain Capital Life Sciences and existing investor Perceptive Xontogeny Venture Fund (PXV) jointly led the financing. Other existing investors also participated. The Boston-based company plans to use the funds to support the clinical … [Read more...] about Cerevasc raises $70M Series B to support eShunt
FDA clears computer-assisted thrombectomy system from Penumbra
Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system. Lightning Flash 2.0 represents the next generation of the company's computer-assisted vacuum thrombectomy (CAVT) technology. It removes the venous thrombus to treat pulmonary emboli (PE). The system features … [Read more...] about FDA clears computer-assisted thrombectomy system from Penumbra
